NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
RemeGen Co. Ltd (PINK: REGMF)
REGMF Technical Analysis
3
As on 25th Apr 2025 REGMF STOCK Price closed @ 5.06 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3.59 & Buy for SHORT-TERM with Stoploss of 4.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
REGMFSTOCK Price
Open | 5.10 | Change | Price | % |
High | 5.10 | 1 Day | 3.56 | 237.33 |
Low | 5.06 | 1 Week | 3.56 | 237.33 |
Close | 5.06 | 1 Month | 3.56 | 237.33 |
Volume | 400 | 1 Year | -1.14 | -18.39 |
52 Week High 6.20 | 52 Week Low 1.50 |
PINK USA Most Active Stocks
TXGE | 3316.21 | 2.69% |
RITE | 0.01 | % |
APLD | 14.09 | -2.83% |
CYBL | 0.01 | 0.00% |
RMSL | 0.01 | 0.00% |
WRFX | 0.01 | % |
AMXVF | 1.05 | 10.53% |
HTZZ | 24.68 | 1.52% |
CRGE | 0.02 | -33.33% |
CRHCF | 61.23 | 0.16% |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
REGMF Daily Charts |
REGMF Intraday Charts |
Whats New @ Bazaartrend |
REGMF Free Analysis |
|
REGMF Important Levels Intraday
RESISTANCE | 5.14 |
RESISTANCE | 5.11 |
RESISTANCE | 5.10 |
RESISTANCE | 5.08 |
SUPPORT | 5.04 |
SUPPORT | 5.02 |
SUPPORT | 5.01 |
SUPPORT | 4.98 |
REGMF Forecast August 2025
4th UP Forecast | 5.06 |
3rd UP Forecast | 5.06 |
2nd UP Forecast | 5.06 |
1st UP Forecast | 5.06 |
1st DOWN Forecast | 5.06 |
2nd DOWN Forecast | 5.06 |
3rd DOWN Forecast | 5.06 |
4th DOWN Forecast | 5.06 |
REGMF Weekly Forecast
4th UP Forecast | 9.30 |
3rd UP Forecast | 7.94 |
2nd UP Forecast | 7.10 |
1st UP Forecast | 6.26 |
1st DOWN Forecast | 3.86 |
2nd DOWN Forecast | 3.02 |
3rd DOWN Forecast | 2.18 |
4th DOWN Forecast | 0.82 |
REGMF Forecast2025
4th UP Forecast | 14.12 |
3rd UP Forecast | 11.21 |
2nd UP Forecast | 9.42 |
1st UP Forecast | 7.62 |
1st DOWN Forecast | 2.5 |
2nd DOWN Forecast | 0.7 |
3rd DOWN Forecast | -1.09 |
4th DOWN Forecast | -4 |
RemeGen Co. Ltd ( PINK USA Symbol : REGMF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
REGMF Other Details
Segment | EQ | |
Market Capital | 6006030848.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
REGMF Address
![]() |
REGMF Latest News
REGMF Business Profile
RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company offers Telitacicept (RC18) for use in the treatment of autoimmune diseases, such as systemic lupus erythematosus, neuromyelitis optica spectrum disorder, rheumatoid arthritis, IgA nephritis, Sjögren's syndrome, multiple sclerosis, and myasthenia gravis; and Disitamab Vedotin (RC48) and RC98 for use in the treatment of various cancers. Its products in various stages of development include RC28, which has completed Phase 1 clinical trials for use in the treatment of wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy; RC88, which is in Phase 1 clinical trials for use in the treatment of mesothelioma, bile duct carcinoma, pancreatic cancer, ovarian carcinoma, lung adenocarcinoma, and other solid tumors, as well as lung and urothelial cancer; RC108 that is in Phase 1 clinical trials to treat various solid tumors; and pre-clinical products, such as RC118, RC138, RC148, and RC158 to treat various solid tumors. The company was incorporated in 2008 and is headquartered in Yantai, the People's Republic of China. Address: 58 Middle Beijing Road, Yantai, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service